• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Graves 眼病患者眼眶成纤维细胞的基因谱分析。

Genetic Profiling of Orbital Fibroblasts from Patients with Graves' Orbitopathy.

机构信息

Department of Clinical and Experimental Medicine, Endocrinology Unit II, University of Pisa and University Hospital of Pisa, Pisa, Italy.

Department of Surgical, Medical and Molecular Pathology, ENT Unit I, University of Pisa and University Hospital of Pisa, Pisa, Italy.

出版信息

J Clin Endocrinol Metab. 2021 Apr 23;106(5):e2176-e2190. doi: 10.1210/clinem/dgab035.

DOI:10.1210/clinem/dgab035
PMID:33484567
Abstract

CONTEXT

Graves' orbitopathy (GO) is an autoimmune disease that persists when immunosuppression is achieved. Orbital fibroblasts from GO patients display peculiar phenotypes even if not exposed to autoimmunity, possibly reflecting genetic or epigenetic mechanisms, which we investigated here.

OBJECTIVE

We aimed to explore potential genetic or epigenetic differences using primary cultures of orbital fibroblasts from GO and control patients.

METHODS

Cell proliferation, hyaluronic acid (HA) secretion, and HA synthases (HAS) were measured. Next-generation sequencing and gene expression analysis of the whole genome were performed, as well as real-time-PCR of selected genes and global DNA methylation assay on orbital fibroblasts from 6 patients with GO and 6 control patients from a referral center.

RESULTS

Cell proliferation was higher in GO than in control fibroblasts. Likewise, HA in the cell medium was higher in GO fibroblasts. HAS-1 and HAS-2 did not differ between GO and control fibroblasts, whereas HAS-3 was more expressed in GO fibroblasts. No relevant gene variants were detected by whole-genome sequencing. However, 58 genes were found to be differentially expressed in GO compared with control fibroblasts, and RT-PCR confirmed the findings in 10 selected genes. We postulated that the differential gene expression was related to an epigenetic mechanism, reflecting diverse DNA methylation, which we therefore measured. In support of our hypothesis, global DNA methylation was significantly higher in GO fibroblasts.

CONCLUSIONS

We propose that, following an autoimmune insult, DNA methylation elicits differential gene expression and sustains the maintenance of GO.

摘要

背景

Graves 眼病(GO)是一种自身免疫性疾病,即使在免疫抑制后仍会持续存在。GO 患者的眼眶成纤维细胞即使未暴露于自身免疫中,也会表现出特殊的表型,这可能反映了遗传或表观遗传机制,我们在此进行了研究。

目的

我们旨在使用来自 GO 和对照患者的眼眶成纤维细胞原代培养物来探索潜在的遗传或表观遗传差异。

方法

测量细胞增殖、透明质酸(HA)分泌和 HA 合酶(HAS)。对整个基因组进行下一代测序和基因表达分析,并对来自 6 名 GO 患者和来自转诊中心的 6 名对照患者的眼眶成纤维细胞进行实时 PCR 和全基因组 DNA 甲基化检测。

结果

GO 成纤维细胞的细胞增殖高于对照成纤维细胞。同样,GO 成纤维细胞培养物中的 HA 也较高。GO 和对照成纤维细胞中的 HAS-1 和 HAS-2 没有差异,而 HAS-3 在 GO 成纤维细胞中表达更高。全基因组测序未发现相关基因变异。然而,与对照成纤维细胞相比,GO 中发现了 58 个基因表达差异,并且 RT-PCR 证实了 10 个选定基因的发现。我们推测,差异基因表达与表观遗传机制有关,反映了不同的 DNA 甲基化,因此我们进行了测量。支持我们的假设,GO 成纤维细胞的总体 DNA 甲基化明显更高。

结论

我们提出,在自身免疫攻击后,DNA 甲基化引发差异基因表达并维持 GO 的维持。

相似文献

1
Genetic Profiling of Orbital Fibroblasts from Patients with Graves' Orbitopathy.Graves 眼病患者眼眶成纤维细胞的基因谱分析。
J Clin Endocrinol Metab. 2021 Apr 23;106(5):e2176-e2190. doi: 10.1210/clinem/dgab035.
2
Integrative Analysis of Proteomics and DNA Methylation in Orbital Fibroblasts From Graves' Ophthalmopathy.Graves 眼病眼眶成纤维细胞蛋白质组学与 DNA 甲基化的综合分析
Front Endocrinol (Lausanne). 2021 Feb 15;11:619989. doi: 10.3389/fendo.2020.619989. eCollection 2020.
3
Novel Roles of Chloroquine and Hydroxychloroquine in Graves' Orbitopathy Therapy by Targeting Orbital Fibroblasts.氯喹和羟氯喹通过靶向眼眶成纤维细胞在格雷夫斯眼眶病治疗中的新作用
J Clin Endocrinol Metab. 2020 Jun 1;105(6):1906-17. doi: 10.1210/clinem/dgaa161.
4
Cell density-dependent stimulation of PAI-1 and hyaluronan synthesis by TGF-β in orbital fibroblasts.转化生长因子-β对眼眶成纤维细胞中纤溶酶原激活物抑制剂-1和透明质酸合成的细胞密度依赖性刺激作用
J Endocrinol. 2016 May;229(2):187-96. doi: 10.1530/JOE-15-0524. Epub 2016 Mar 15.
5
Chemokine Expression during Adipogenesis and Inflammation in Orbital Fibroblasts from Patients with Graves' Orbitopathy.格雷夫斯眼眶病患者眼眶成纤维细胞脂肪生成和炎症过程中的趋化因子表达
Korean J Ophthalmol. 2020 Jun;34(3):192-202. doi: 10.3341/kjo.2020.0002.
6
Antioxidant effects of β-carotene, but not of retinol and vitamin E, in orbital fibroblasts from patients with Graves' orbitopathy (GO).β-胡萝卜素的抗氧化作用,而不是视黄醇和维生素 E,在格雷夫斯眼病(GO)患者的眼眶成纤维细胞中。
J Endocrinol Invest. 2018 Jul;41(7):815-820. doi: 10.1007/s40618-017-0809-5. Epub 2017 Dec 18.
7
Search of reference biomarkers reflecting orbital tissue remodeling in the course of Graves' orbitopathy.寻找反映格雷夫斯眼眶病病程中眼眶组织重塑的参考生物标志物。
Folia Histochem Cytobiol. 2020;58(1):37-45. doi: 10.5603/FHC.a2020.0003. Epub 2020 Mar 16.
8
Histone Deacetylase 4 Controls Extracellular Matrix Production in Orbital Fibroblasts from Graves' Ophthalmopathy Patients.组蛋白去乙酰化酶 4 控制格雷夫斯眼病患者眼眶成纤维细胞细胞外基质的产生。
Thyroid. 2021 Oct;31(10):1566-1576. doi: 10.1089/thy.2020.0948. Epub 2021 Aug 18.
9
Adipose tissue depot-specific differences in the regulation of hyaluronan production of relevance to Graves' orbitopathy.与格雷夫斯眼病相关的透明质酸产生的脂肪组织库特异性调节的差异。
J Clin Endocrinol Metab. 2012 Feb;97(2):653-62. doi: 10.1210/jc.2011-1299. Epub 2011 Dec 7.
10
MicroRNA-27 inhibits adipogenic differentiation in orbital fibroblasts from patients with Graves' orbitopathy.微小 RNA-27 抑制格雷夫斯眼病患者眼眶成纤维细胞的成脂分化。
PLoS One. 2019 Aug 15;14(8):e0221077. doi: 10.1371/journal.pone.0221077. eCollection 2019.

引用本文的文献

1
In vivo and in vitro evidence for a protective role of autoantibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves' orbitopathy.自身抗体对格雷夫斯眼眶病中胰岛素样生长因子-1受体(IGF-1R)具有保护作用的体内和体外证据。
Endocrine. 2025 Mar 29. doi: 10.1007/s12020-025-04219-6.
2
Multi-Omics Approaches to Discover Biomarkers of Thyroid Eye Disease: A Systematic Review.发现甲状腺眼病生物标志物的多组学方法:系统评价
Int J Biol Sci. 2024 Nov 11;20(15):6038-6055. doi: 10.7150/ijbs.103977. eCollection 2024.
3
Role of genetics and epigenetics in Graves' orbitopathy.
遗传学和表观遗传学在格雷夫斯眼病中的作用。
Eur Thyroid J. 2024 Nov 6;13(6). doi: 10.1530/ETJ-24-0179. Print 2024 Dec 1.
4
Long-term outcome of Graves' orbitopathy following treatment with sirolimus.西罗莫司治疗格雷夫斯眼眶病的长期疗效
J Endocrinol Invest. 2025 Mar;48(3):607-618. doi: 10.1007/s40618-024-02470-8. Epub 2024 Oct 7.
5
Therapeutic role of histone deacetylase inhibition in an model of Graves' orbitopathy.组蛋白去乙酰化酶抑制在格雷夫斯眼病模型中的治疗作用。
Mol Med Rep. 2024 Dec;30(6). doi: 10.3892/mmr.2024.13342. Epub 2024 Sep 27.
6
EZH2 as a major histone methyltransferase in PDGF-BB-activated orbital fibroblast in the pathogenesis of Graves' ophthalmopathy.EZH2 作为 PDGF-BB 激活眼眶成纤维细胞中的主要组蛋白甲基转移酶在 Graves 眼病发病机制中的作用。
Sci Rep. 2024 Apr 4;14(1):7947. doi: 10.1038/s41598-024-57926-x.
7
Understanding the clinical and molecular basis of thyroid orbitopathy: a review of recent evidence.了解甲状腺眼病的临床和分子基础:对最新证据的综述。
Hormones (Athens). 2024 Mar;23(1):25-34. doi: 10.1007/s42000-023-00498-8. Epub 2023 Nov 1.
8
Machine learning-based prediction of diagnostic markers for Graves' orbitopathy.基于机器学习的 Graves 眼病诊断标志物预测。
Endocrine. 2023 Aug;81(2):277-289. doi: 10.1007/s12020-023-03349-z. Epub 2023 Apr 15.
9
Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study.代谢性疾病中的表观遗传调控:机制及临床研究进展。
Signal Transduct Target Ther. 2023 Mar 2;8(1):98. doi: 10.1038/s41392-023-01333-7.
10
Ceruloplasmin regulating fibrosis in orbital fibroblasts provides a novel therapeutic target for Graves' orbitopathy.铜蓝蛋白调控眼眶成纤维细胞纤维化,为格雷夫斯眼病的治疗提供了新靶点。
J Endocrinol Invest. 2023 Oct;46(10):2005-2016. doi: 10.1007/s40618-023-02033-3. Epub 2023 Feb 27.